A paper published in Clinical Rheumatology from the research group of our Scientific Officer Manuel Castro Cabezas and Chief Scientific Officer Rick Grobbee indicates that patients with rheumatoid arthritis with high liver fibrosis scores are likely to have a higher risk of cardiovascular events. Incorporating fibrosis measurements into routine clinical care for rheumatoid arthritis patients could identify individuals with highest risk and enable risk management strategies.

Read more here  or reach out to our experts if you have any questions.